UCSF Limited Submission Opportunities
(Applications through UCSF Limited Submission Program)
- Internal Deadline: Oct 6, 2026
Susan G. Komen Foundation Inflammatory Breast Cancer (IBC) Research Grant: Biological Underpinnings of IBC
This program aims to unlock new knowledge about the biological mechanisms driving inflammatory breast cancer (IBC), stimulating the exploration of new ideas and areas of investigation with significant potential to improve IBC patient care and outcomes. - Internal Deadline: Oct 7, 2026
National Comprehensive Cancer Network (NCCN) Young Investigator Award
This program aims to identify and fund top investigators in the early stages of their careers interested in participating and contributing to cancer research. - Internal Deadline: Oct 7, 2026
NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)
Supports academic hubs that help translate promising biomedical discoveries into products and technologies and advance them toward commercialization, entrepreneurship, and follow-on investment. - Internal Deadline: Oct 8, 2026
Vallee Scholars
Provides flexible funding for exceptional, independent investigators carrying out bold and innovative basic biomedical research.
Intramural Funding Opportunities
For questions about intramural awards, please contact Meredith Donnelly.
- Deadline: Oct 1, 2026
UCSF Center for Reproductive Sciences Request for Pilot Project Proposal
UCSF faculty are invited to apply for up to $50,000 in pilot funding for innovative research on the immunological, epigenetic, and developmental determinants of fertility and infertility. Proposals from a variety of disciplines and perspectives are encouraged. - Deadline: Oct 26, 2026
UCSF Prostate Cancer Program Pilot Awards
The UCSF Prostate Cancer Program announces an opportunity for pilot research funding in any area of investigation in prostate cancer. Funds are available to support multiple proposals. All areas of prostate cancer research including computational, laboratory, translational, clinical, and population sciences are eligible.
Foundations/Other Sources
- Deadline: Nov 9, 2026
Pancreatic Cancer Action Network (PCAN) Collaborative Catalyst Research Award
This award aims to progress in pancreatic cancer through collaborative, multi-institutional team science, tackling problems that demand coordinated expertise and are unlikely to be addressed by any single laboratory or investigator alone. This award supports one unified application, not a collection of separate sub-projects. - Deadline: Nov 13, 2026
Upstream Research Center Pilot Grants
The Upstream Research Center, co-led by Stanford, UC Davis, and UCSF, invites applications for pilot grants focused on the social drivers of cancer in areas experiencing persistent poverty. Projects must focus on research relevant to exposures experienced in persistent poverty areas in Northern California. - Deadline: Dec 1, 2026
AACR-Kids Beating Cancer Margaret Guedes Monosomy 7 Legacy Cancer Research Grant
This grant supports innovative research to improve understanding and treatment of monosomy 7 AML and other rare, high-risk AML subtypes, with the goal of improving patient outcomes. - Deadline: Dec 9, 2026
Pancreatic Cancer Action Network (PCAN) Career Development Award
This award aims to encourage and support junior faculty to conduct pancreatic cancer research and establish successful career paths in this field. The research proposed for funding may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pancreatic cancer.
NIH Announcements
If you are a Cancer Center member who is interested in applying and receiving grant writing support, please contact Erin Bank.
To view NCI funding opportunities, search here.
In accordance with Federal and State law and University policy, the University of California does not discriminate on the basis of age, gender, race, ethnicity, national origin, religion, sexual orientation, gender identity, health, or disability. For detailed information, please visit the Office for the Prevention of Harassment and Discrimination.